Biotech

All Articles

AstraZeneca pays for CSPC $100M for preclinical heart disease medicine

.AstraZeneca has settled CSPC Drug Group $one hundred million for a preclinical heart attack medicin...

Zephyrm finds Hong Kong IPO to money stage 3 cell therapy trials

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, submission (PDF) for an ...

Frazier Life Sciences gathers $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced a better $630 million for its fund focused on little...

GigaGen gathers as much as $135M BARDA money to beat botulism

.Antitoxin enthusiast GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own specia...

GPCR company Septerna declare IPO on durability of preclinical data

.Septerna will figure out how a biotech without "any significant scientific information" meals in th...

Kurma shuts first $154M payload for largest biotech fund as yet

.European VC agency Kurma Allies has actually introduced its own most recent biotech fund, with 140 ...

Prothena markets one director while another places-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...

Editas capitalize Tip Cas9 licensing legal rights for $57M

.Versus the background of a Cas9 patent battle that declines to die, Editas Medicine is moneying in ...

Ultragenyx adjusts gene therapy dosing to call up effectiveness

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson disease genetics treatment UX70...

Biopharma layoff rate maintains in Q3: Brutal Biotech evaluation

.As summertime heat turns to cool down winds, hopes that this year would certainly deliver extensive...